Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(46 sites) United States
Local Institution - 0070, Los Angeles, California Local Institution - 0107, Chicago, Illinois John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey Local Institution - 0100, Mineola, New York Local Institution - 0080, Portland, Oregon Local Institution - 0111, Portland, Oregon Local Institution - 0022, Nashville, Tennessee Local Institution - 0102, Nashville, Tennessee Local Institution - 0083, Seattle, Washington Australia
Royal Prince Alfred Hospital, Camperdown, New South Wales Local Institution - 0033, Westmead, New South Wales Local Institution - 0040, Birtinya, Queensland Local Institution - 0096, Melbourne Chile
Local Institution - 0064, Santiago, Santiago Metropolitan Local Institution - 0106, Santiago Region Metropolitana, Santiago Metropolitan China
Local Institution - 0075, Guangzhou, Guangdong Local Institution - 0086, Xi'an, Shaanxi Local Institution - 0078, Shanghai, Shanghai Municipality France
Local Institution - 0056, Pessac, Aquitaine Local Institution - 0004, Grenoble, Isère Local Institution - 0018, Saint Priest En Jarez, Pays de la Loire Region Local Institution - 0003, Bobigny Germany
Local Institution - 0031, Cologne, North Rhine-Westphalia Local Institution - 0028, Kiel, Schleswig-Holstein Local Institution - 0030, Frankfurt Italy
Local Institution - 0109, Pisa, Tuscany Local Institution - 0088, Milan Local Institution - 0016, Pisa Local Institution - 0046, Rozzano (MI) Poland
Local Institution - 0021, Wroclaw, Lower Silesian Voivodeship Local Institution - 0105, Warsaw, Masovian Voivodeship Local Institution - 0020, Gdansk Singapore
Local Institution - 0009, Singapore Local Institution - 0012, Singapore South Korea
Local Institution - 0027, Seongnam-si, Gyeonggi-do Local Institution - 0013, Seoul, Seoul Teugbyeolsi Local Institution - 0011, Seoul, Seoul-teukbyeolsi Spain
Local Institution - 0014, Pamplona, Navarre Local Institution - 0060, Madrid Taiwan
Local Institution - 0032, Taichung National Cheng Kung University Hospital, Tainan Local Institution - 0006, Taipei Taipei Veterans General Hospital, Taipei United Kingdom
Hammersmith Hospital, London, London, City of Local Institution - 0051, Glasgow, South Western Scotland Local Institution - 0053, Metropolitan Borough of Wirral